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Directed transport of neutrophil-derived
extracellular vesicles enables platelet-mediated
innate immune response
Jan Rossaint1, Katharina Ku¨hne1, Jennifer Skupski1, Hugo Van Aken1, Mark R. Looney2, Andres Hidalgo3,4
& Alexander Zarbock1
The innate immune response to bacterial infections requires the interaction of neutrophils
and platelets. Here, we show that a multistep reciprocal crosstalk exists between these two
cell types, ultimately facilitating neutrophil influx into the lung to eliminate infections.
Activated platelets adhere to intravascular neutrophils through P-selectin/P-selectin
glycoprotein ligand-1 (PSGL-1)-mediated binding, a primary interaction that allows platelets
glycoprotein Iba (GPIba)-induced generation of neutrophil-derived extracellular vesicles
(EV). EV production is directed by exocytosis and allows shuttling of arachidonic acid
into platelets. EVs are then specifically internalized into platelets in a Mac1-dependent
fashion, and relocated into intracellular compartments enriched in cyclooxygenase1 (Cox1),
an enzyme processing arachidonic acid to synthesize thromboxane A2 (TxA2). Finally,
platelet-derived-TxA2 elicits a full neutrophil response by inducing the endothelial expression
of ICAM-1, intravascular crawling, and extravasation. We conclude that critical
substrate–enzyme pairs are compartmentalized in neutrophils and platelets during steady
state limiting non-specific inflammation, but bacterial infection triggers regulated EV shuttling
resulting in robust inflammation and pathogen clearance.
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T
he acute respiratory distress syndrome (ARDS) is a life
threatening disease with a high incidence1. Despite
improved supportive care, the mortality of ARDS
remains high at B40% (ref. 1). ARDS is characterized by an
increased number of neutrophils in the lung and increased
permeability, leading to lung oedema and consequently to
decreased pulmonary gas exchange1,2. Major causes for the
development of ARDS are pneumonia and sepsis, and
Gram-negative bacteria are the dominant pathogens3. The
recruitment of neutrophils into inflamed tissue is required for
eliminating invading pathogens, but they are also involved in tissue
destruction by releasing a variety of enzymes4. Extravasation of
neutrophils in peripheral tissues proceeds in a cascade-like fashion4,
whereas the mechanisms of neutrophil recruitment into the
inflamed lung are still poorly defined5. During pneumonia,
neutrophils may also form heterotypic aggregates with other
blood-born cells such as platelets6. This interaction between
platelets and neutrophils promotes neutrophil recruitment and
activation7–11, thus modulating the innate immune response12.
Recent studies provide evidence for the significance of platelets in
mouse models of acid-induced acute lung injury9,13 and transfus-
ion-related acute lung injury7,10,11,14. During inflammation,
platelets accumulate at sites of inflamed vascular endothelium and
present P-selectin on their surface. P-selectin can bind to PSGL-1
on circulating neutrophils, which then adhere to platelets6,15,16.
Apart from P-selectin binding to PSGL-1, bonds between activated
platelets and neutrophils may also be formed by the platelet integrin
aIIbbIII (GPIIbIIIa) binding to the neutrophil integrin aMb2 (Mac-1)
via fibrinogen as well as direct binding of Mac-1 on neutrophils to
platelet GPIba (refs 6,17,18). The interaction of platelets with
neutrophils fully activates neutrophils8,10,19. During inflammatory
processes neutrophils may generate extracellular vesicles (EV)20.
EVs are actively secreted from neutrophils and may contain certain
subsets of cytosolic and membrane-bound molecules. Previous
reports suggest that the generation and liberation of EVs derived
from various cells is a highly organized process involving cell-
autonomous excretory mechanisms and suggests that the uptake of
EVs into target cells is also mediated by distinct molecular
mechanisms21,22. However, the exact role of EVs in inflammat-
ion, particularly in platelet–neutrophil interactions, and the
molecular mechanism regulating their excretion and uptake
remain poorly defined.
The interaction of platelets and neutrophils leads to neutrophil
activation by integrin-mediated outside-in-signalling in addition to
the presentation of chemokines and lipid mediators by platelets to
neutrophils23–27. One important lipid mediator is thromboxane A2
(TxA2)28. TxA2 is an arachidonic acid metabolite which is
generated in several cell types and tissues, such as platelets,
inflammatory cells and pulmonary tissue, by the enzymes
cyclooxygenase, hydroperoxidase and tissue-specific isomerases29.
The biosynthetic pathway for TxA2 production is mostly shared
with that of other prostaglandins. Phospholipase A2 releases
arachidonic acid from membrane phospholipids, which is
the substrate for a metabolic pathway involving cycloogygenase
(Cox)-1 and Cox2 and hydroperoxidase to form prostaglandin
H2 (PGH2). Thromboxane synthase is the most abundant
isomerase in platelets and converts PGH2 to TxA2, which in turn
has a short half-life and is converted to its stable metabolite
thromboxane B2 (TxB2).
The aim of the present study was to investigate the molecular
mechanisms by which neutrophils contribute to thromboxane
generation in platelets and the pathophysiological implications of
this process during bacterial infection. Unexpectedly, we found
that this process is enabled through cooperative metabolic
processing and metabolite transport via EVs between neutrophils
and platelets.
Results
TxA2 generation is regulated by complex formation. Cox1 is
involved in the production of prostaglandins, such as TxA2, from
arachidonic acid. We analysed thromboxane production from
platelets and neutrophils individually, and in combination, after
stimulation with ADP and fMLP, two potent agonists for platelets
and neutrophils, respectively. Production of TxB2, the stable
metabolite of TxA2, was significantly increased when platelets
and neutrophils were co-incubated, and blocking the physical
interaction between both cell types by pretreating the cells with
blocking antibodies against either P-selectin or PSGL-1 decreased
TxB2 production (Fig. 1a). Because the two cells can synthesize
prostaglandins, we next investigated the cellular source of
arachidonic acid required for TxB2 production. We incubated
neutrophils, platelets or both cell types with radioactively
labelled arachidonic acid (C14-AA) and measured the production
of radio-labelled thromboxane B2 (TxB2-C14) after stimulation of
both cell types with ADP and fMLP. This assay revealed that
neutrophils provide a significant amount of arachidonic acid and
that maximum TxB2 production is only achieved when both
cellular sourced of arachidonic acid (that is, neutrophils and
platelets) cooperate in prostaglandin production (Fig. 1b). To
ensure equal labelling of platelets and neutrophils in this assay,
the radioactive counts per minute (c.p.m.) of cell lysates with
equal protein content (indicating equal cell masses) were analysed
using a b-counter to verify equal C14-AA loading. To differentiate
the role of Cox1 and Cox2 in platelets and neutrophils in
TxB2-C14 production using arachidonic acid from neutrophils,
we isolated neutrophils and platelets from wild-type (WT),
Cox1 / and Cox2 / mice and incubated only the
neutrophils with AA-C14. Afterwards, neutrophils and platelets
were coincubated and TxB2-C14 production and total TxB2 levels
were analysed. We observed that only Cox1 in platelets is
necessary for TxB2 production utilizing arachidonic acid from
neutrophils (Fig. 1c,d). To identify molecular adhesion
molecules required for intercellular interactions and exchange of
arachidonic acid during thromboxane production by platelets, we
used a blocking anti-P-selectin antibody (RB40.34) and
anti-PSGL-1 antibody (4RA10) as well as tirofiban (antagonist of
the platelet integrin aIIbbIII) and demonstrated that TxB2-C14
production and overall TxB2 production was reduced after
blockade of P-selectin or PSGL-1, but not after inhibiting the
platelet integrin aIIbbIII (Fig. 1e,f). Notably, the activity of
Cox1 was increased in the presence of neutrophils, and again this
effect was reversed after blocking P-selectin or PSGL-1, but not
aIIbbIII (Fig. 1g).
Escherichia coli-induced pneumonia is platelet dependent.
Platelet depletion has been shown to reduce neutrophil
recruitment, vascular permeability, and tissue destruction in sterile
models of acute lung inflammation7,9,10,13. To investigate whether
platelets potentiate productive neutrophil recruitment and bacterial
clearance during pneumonia triggered by E. coli, mice were platelet
depleted by triple injections of busulfan as reported previously8.
Intratracheal instillation of E. coli in platelet-depleted mice led to a
significantly reduced survival rate compared with control mice
(Fig. 2a). E. coli instillation produced an increased neutrophil
count in the BAL (Fig. 2b) and a detectable number of colony-
forming units (c.f.u’s) in the bronchoalveolar lavage (BAL), lung
and spleen (Fig. 2c–e). Platelet depletion by busulfan decreased the
number of neutrophils in the BAL (Fig. 2b) and significantly
increased bacterial burden in the BAL, lung and spleen (Fig. 2c–e)
after E. coli instillation compared with vehicle-treated mice. The
same effect was observed when platelets were depleted with a
different approach utilizing a platelet-depleting antibody
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Figure 1 | Thromboxane generation by platelets is enabled by interacting with neutrophils. (a) PMNs and platelets were isolated fromWTmice and TxB2
production in both cell types alone as well as after co-incubation under control conditions or stimulation with ADP (10mM) and fMLP (10mM) was
analysed in the presence or absence of blocking antibodies against P-selectin (clone RB40.34. 5mgml 1) or PSGL-1 (4RA10, 5 mgml 1) (n¼ 3). (b) PMNs
and/or platelets from WTmice were radioactively labelled with C14-AA and TxB2-C
14 in control and ADP/fMLP-stimulated samples was measured (n¼ 3).
PMNs and platelets were isolated from WTmice, Cox1 / and Cox2 / mice and only PMN were radioactively labelled with C14-AA. (c) TxB2-C14 in
control and ADP/fMLP-stimulated samples (n¼ 3). (d) Total TxB2 production in control and ADP/fMLP-stimulated samples (n¼ 3). PMNs and platelets
were isolated from WTmice and treated with blocking antibodies against P-selectin (clone RB40.34, 5mgml 1), PSGL-1 (clone 4RA10, 5 mgml 1) or
tirofiban (100mM). (e) TxB2-C14 in control and ADP/fMLP-stimulated samples (n¼ 3). (f) Total TxB2 production in control and ADP/fMLP-stimulated
samples (n¼ 3). (g) Cox1 activity in platelets alone and after co-incubation with neutrophils (n¼ 3). Mean±s.e.m., ANOVA plus Bonferroni testing,
*Po0.05.
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(Supplementary Fig. 2a–d). In a murine model of pneumonia
induced by intratracheal instillation of the clinically relevant
pathogen Klebsiella pneumoniae, platelet depletion also decreased
the number of neutrophils in the BAL (Supplementary Fig. 1a) and
significantly increased bacterial burden in the BAL, lung and
spleen (Supplementary Fig. 1b–d). To exclude adverse effects of
busulfan treatment on neutrophil function, we isolated neutrophils
from control- and busulfan-treated mice and analysed ICAM-1
binding, transmigration and phagocytosis of E. coli particles
in vitro. These experiments showed that all these neutrophil
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Figure 2 | Platelets are required host defence during E. coli-induced pneumonia. Glycol- and busulfan-treated wild-type mice were injected
intratracheally with saline or viable E. coli. (a) Survival 24 h after instillation of 8 106 viable E. coli (n¼ 11–15). (b) Neutrophil recruitment into the alveoli
and the c.f.u. count in the BAL (c), lung tissue (d) and the spleen (e) were analysed 24h after intratracheal instillation of 6 106 c.f.u.’s per mouse (n¼4).
Neutrophil accumulation in the lung was visualized by intravital microscopy of the middle right lung lobe by intravital microscopy. (f) Number of
accumulated neutrophils per field of view (FOV) (n¼ 3). (g) Neutrophils interacting with platelets in the lung capillaries in vivo (n¼ 3). (h) The formation of
circulating platelet–neutrophil aggregates in the blood of glycol- and busulfan-treated mice after intratracheal instillation of saline or viable E. coli (6 106
c.f.u.’s per mouse) was measured by flow cytometry (n¼4). (i) Ultrathin cross-sectioned lung tissue imaged by transmission electron microscopy from
lung tissue of WTmice after inducing pneumonia showing a neutrophil (*) in close proximity to a platelet (#) and 2 erythrocytes (y) within the boundaries
of the capillary wall (black arrow). (j) Confocal image of lung tissue from WTmice after induction of E. coli pneumonia with (k) 3D reconstruction and
(l) exemplary display of a single confocal plane to identify neutrophils (Ly6G, green) and platelets (CD41, red) within pulmonary capillaries stained with
PECAM-1 antibody (gray) (scale bars equal 20mm). Mean±s.e.m., ANOVA plus Bonferroni testing, *Po0.05.
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functions were not significantly altered by busulfan (Supplemen-
tary Fig. 2e–g). To directly visualize neutrophil accumulation in the
lung during E. coli-induced pneumonia, we employed intravital
microscopy in living mice. Instillation of E. coli caused a significant
increase in neutrophil accumulation in the lung microvasculature,
which was markedly reduced in platelet-depleted mice (Fig. 2f). In
addition, platelet depletion caused an expected reduction in the
number of platelet–neutrophil aggregates (Fig. 2g). To investigate
circulating platelet–neutrophil aggregates, we used a flow
cytometry based analysis method9. The number of circulating
platelet–neutrophil aggregates in the peripheral blood significantly
increased after instillation of E. coli (Fig. 2h), whereas platelet
depletion significantly decreased the amount of circulating
platelet–neutrophil aggregates (Fig. 2h). The presence of platelet–
neutrophil aggregates in the microcirculation of the lung after
E. coli instillation was also demonstrated by transmission electron
microscopy (Fig. 2i). To further visualize the allocation of platelets
and neutrophils during E. coli induced pneumonia we stained
neutrophils, platelets and PECAM as an endothelial marker of the
pulmonary microvasculature and analysed lung sections from
E. coli-treated animals by confocal microscopy (Fig. 2j–l).
Together, these data demonstrate that platelets activate
neutrophil recruitment during bacterial infection.
Host defence from pneumonia requires hematopoietic Cox1.
TxA2 has been involved in the pathogenesis of pneumonia9. To
investigate whether Cox1 or Cox2 are necessary for neutrophil
recruitment and bacterial clearance during E. coli-induced
pneumonia, we intratracheally instilled viable E. coli into WT,
Cox1 / and Cox2 / mice. Cox1 deficiency, but not Cox2
deficiency, caused a significantly decreased number of recruited
neutrophils in the BAL after E. coli instillation (Supplementary
Fig. 3a). Consequently, Cox1 / mice had a significantly
higher c.f.u. count in the BAL, lung and spleen (Supplementary
Fig. 3b–d) following E. coli instillation compared with WT and
Cox2 / mice. By using bone marrow chimeric mice, we
demonstrated that Cox1 deficiency in hematopoietic cells caused
a reduced number of neutrophils in the BAL and impaired
bacterial clearance, as indicated by increased c.f.u.’s in the BAL,
lung and spleen (Supplementary Fig. 3e–h). Instillation of E. coli
caused a significant higher number of neutrophils in the lung
microvasculature of WT mice compared with Cox1 / mice, as
revealed by intravital microscopy (Supplementary Figs 3i and 4).
In addition, platelet–neutrophil interactions were significantly
decreased in Cox1 / mice compared with WT mice after E. coli
instillation (Supplementary Figs. 3j and 4). Cox1 deficiency led to
a significantly reduced survival rate compared with vehicle-
treated control mice (Supplementary Fig. 3k). Likewise, Cox1-
deficient mice after infection with K. pneumoniae also had an
impaired neutrophil recruitment into the lung (Supplementary
Fig. 1a) resulting in higher c.f.u. counts in the BAL, lung tissue
and spleen compared with control animals (Supplementary
Fig. 1b–d). These findings are consistent with our previous
observation that platelet-derived Cox1, but not Cox2, is needed
for the synthesis of TxA2 upon contact with neutrophils (Fig. 1).
Blocking the thromboxane receptor aggravates pneumonia.
Our data indicate that Cox1 in platelets is required for
thromboxane A2 production, neutrophil recruitment, and
bacterial clearance during E. coli and K. pneumoniae-induced
pneumonia. To demonstrate that the interaction of platelets and
neutrophils is necessary for adequate thromboxane production
in vivo, we measured the serum TxB2 levels in mice after inducing
E. coli-induced pneumonia and found that serum TxB2 levels are
significantly decreased in platelet-depleted mice after E. coli
instillation (Fig. 3a). Neutrophil depletion, or blockade of
P-selectin or PSGL-1 significantly decreased serum TxB2 levels in
mice after inducing E. coli-induced pneumonia (Fig. 3a). Thus
neutrophil–platelet contacts mediated by PSGL-1 is required for
thromboxane production during pulmonary infection. To
investigate the role of the thromboxane receptor during
E. coli-induced pneumonia, we pretreated mice with a
thromboxane receptor inhibitor (SQ 29548) and found a sig-
nificantly decreased number of neutrophils in the BAL (Fig. 3b)
and a significantly increased number of c.f.u.’s in the BAL, lung
and spleen after E. coli instillation (Fig. 3c–e). Blocking P-selectin
or PSGL-1 also reduced the number of neutrophils in the BAL
(Fig. 3b) and increased the number of c.f.u.’s in the BAL, lung and
spleen (Fig. 3c–e). We previously reported impaired neutrophil
recruitment to the lungs after blocking the platelet integrin
aIIbbIII using tirofiban in a murine model of ventilator-associated
lung injury, and we could also observe reduced neutrophil
recruitment and impaired bacterial clearance in the E. coli-
induced pneumonia model after tirofiban administration
(Fig. 3b–e)8. To specifically demonstrate that platelet and
not endothelial P-selectin is responsible for these effect we
transplanted bone marrow from P-selectin-deficient donor mice
(Selp / ) into lethally irradiated WT recipient mice and vice
versa. Pneumonia was induced in these mice 6 weeks after bone
marrow transplantation. Mice transplanted with Selp / bone
marrow showed a significantly reduced number of neutrophils in
the BAL (Supplementary Fig. 5a) and increased number of c.f.u.’s
in the BAL, lung and spleen after E. coli instillation
(Supplementary Fig. 5b–d) compared with control mice
transplanted with WT bone marrow. Bacterial infections are
known to cause a local and systemic inflammatory response
including the release of formylated peptides and
pro-inflammatory mediators causing platelet activation in vivo.
To directly demonstrate upregulation of P-selectin surface
expression on platelets in vivo, we induced pneumonia by
E. coli instillation in WT mice, isolated circulating platelets from
blood after 4, 12 and 24 h and analysed platelet P-selectin
expression by flow cytometry. We demonstrated that platelets
from E. coli-treated mice expressed significantly more P-selectin
on their cell surface compared with platelets isolated from
saline-treated mice (Supplementary Fig. 5e). Intravital
microscopy revealed a reduced number of adherent neutrophils
in the lung microvasculature in mice pretreated with the
thromboxane receptor inhibitor after E. coli instillation (Fig. 3f).
Consequently, thromboxane receptor blockade resulted in a
reduced survival after inducing E. coli-induced pneumonia
(Fig. 3g), which indicated that TxA2 is required for neutrophil
recruitment and host defence during E. coli-induced pneumonia.
Neutrophil-derived EV transfer arachidonic acid to platelets.
Activated neutrophils may generate and release EVs under
inflammatory conditions. The number of EVs released after
ADP/fMLP (10 mM each) stimulation was strongly increased in
the presence of platelets (Fig. 4a). This effect was inhibited by
pretreatment of platelets with blocking antibodies against either
P-selectin (clone RB40.34, 5 mgml 1) or GPIba (clone Xia.B2,
5 mgml 1) (Fig. 4a). To investigate the presence of arachidonic
acid in EVs, we isolated EVs from the supernatants of neutrophils
co-cultured or not with platelets and assessed the levels of
arachidonic acid. The incubation of neutrophils together with
platelets, versus neutrophils alone, increased the amount of
arachidonic acid in the EV fraction (Fig. 4b). Confocal imaging
revealed that platelets readily take-up isolated and fluorescently-
labelled neutrophil-derived EVs (Fig. 4c). Likewise, confocal
imaging also showed that neutrophil-derived EVs were
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incorporated into platelets during platelet-neutrophil interactions
(Fig. 4d) and, interestingly, neutrophil-derived EVs co-localized
with platelet Cox1 (Fig. 4e). Having shown that the blocking
GPIba reduces EV release from neutrophils, we investigated
thromboxane production and observed that GPIba blockade
reduces both the TxB2-C14 release, indicating reduced usage of
neutrophil-derived arachidonic acid by platelets, as well as total
thromboxane production (Fig. 4f,g). In agreement with this
finding, GPIba blockade (clone Xia.B2, 5mgml 1) reduced
platelet Cox1 activity (Fig. 4h). The addition of isolated EVs
to the platelet-neutrophil co-culture after GPIba blockade was
able to rescue TxB2-C14 release, total thromboxane production
and platelet Cox1 activity (Fig. 4f–h). Consequently, blocking
GPIba caused a significantly decreased number of neutrophils in
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the BAL after instillation of viable 6 106 c.f.u.’s of E. coli/mouse
(Fig. 4j) and a significantly increase in the c.f.u. count in
the BAL, lung and spleen (Fig. 4k–m) and the amount of
circulating platelet–neutrophil aggregates in the blood stream
(Fig. 4i). Importantly, reconstitution with neutrophil-derived EVs
(2 107 per ml) improved survival in mice after blocking of
GPIba (Fig. 4n). Besides thromboxane, the biosynthesis of
leukotrienes is also known to involve platelet–neutrophil interaction.
While LTB4 synthesis by neutrophils relies on transcellular
substrate transport from platelets to neutrophils, platelets require
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neutrophil-derived LTA4 for transformation to LTC4 (ref. 30).
The concentrations of both LTB4 and LTC4 were increased under
stimulated compared with control conditions. However, blocking
GPIba did not significantly impact LTB4 or LTC4 production,
indicating the implication of different modulatory molecular
mechanisms in comparison to thromboxane biosynthesis
(Fig. 4o,p). Together, these findings indicated that TxA2
production and host defence is dependent on platelet-borne
Cox1, which utilizes neutrophil-derived arachidonic acid
shuttled into platelets via EVs.
EV shuttling involves directed release and uptake mechanisms.
The spatiotemporal proximity of the neutrophil–platelet
interactions implies that the generation of neutrophil-derived
EVs may be a directed process. Caveolin-1 and clathrin are
known to be involved into cellular vesicle transport by regulating
endosomal sorting and exocytosis, and vesicle internalization,
respectively31,32. We analysed the presence of the endosomal
marker caveolin-1 and clathrin on neutrophil-derived EVs by
western blot and found both to be expressed (Fig. 5a).
The endosomal marker caveolin-1 is known to be involved in
vesicle exocytosis. Specifically blocking exocytosis by neutrophil
pretreatment with BAPTA-AM significantly reduced the
generation of neutrophil-derived EVs (Fig. 5b). The vesicular
coating molecule clathrin plays a well characterized role in vesicle
internalization into living cells. Blocking clathrin-dependent
vesicle internalization with chlorpromazine significantly
decreased the production of TxA2, indicating decreased EV
uptake into platelets (Fig. 5c). Western blot analysis of
neutrophil-derived EVs also revealed the presence of the
adhesion molecule Mac-1 on these vehicles (Fig. 5d).
Pretreatment of neutrophil-derived EVs with a blocking Mac-1
antibody significantly decreased the production of TxA2,
indicating decreased EV uptake into platelets (Fig. 5e). The
combination of chlorpromazine treatment and a blocking Mac-1
antibody did not show an additional effect in platelet binding or
TxA2 production, indicating that both Mac-1 and clathrin
cooperate for the uptake of neutrophil-derived EVs by platelets
(Fig. 5e,f). To further prove that EVs are internalized by platelets,
isolated neutrophil-derived EVs were co-incubated with platelets,
followed by isolation of washed platelets. Western blot analysis of
these platelet preparations demonstrated the presence of Mac-1
in platelet lysates after co-incubation with neutrophil-derived EVs
(Fig. 5g). Finally, we investigated whether the inhibition of Mac-1
dependent neutrophil-derived EV uptake into platelets would also
affect survival during E. coli-induced pneumonia in vivo. GPIba
antibody-treated animals, which are susceptible to bacterial
spread (Fig. 4i), were reconstituted with neutrophil-derived EVs
that had been incubated with or without Mac-1 antibody.
While reconstitution with untreated EVs improved survival,
pretreatment of EVs with a blocking Mac-1 antibody before
reconstitution did not affect survival after induction of
pneumonia (Fig. 5h). Thus, neutrophil-derived EVs are
essential for immune protection of infected lungs by acting on
platelets. Previous reports on reverse transcellular
communication by EV transport from activated platelets
to neutrophils imply a possible Cox1 shuttling from platelets to
neutrophils. However, we investigated the activity of Cox1 after
co-incubation of isolated WT neutrophils with either WT or
Cox1 / platelets and could not detect a significant difference in
neutrophils (Fig. 5i). Interestingly, the reconstitution of
GPIba-treated animals with isolated EVs improved survival
after induction of pneumonia (Fig. 4n). We induced pneumonia
in GPIba-treated animals that were consecutively reconstituted
with isolated EVs that had been treated with the GPIba blocking
antibody in vitro before re-injection into the animals. The direct
GPIba blockade prevented the rescue of the phenotype and led to
impaired neutrophil recruitment and increased bacterial c.f.u.
numbers in the BAL, lung and spleen of these animals compared
with GPIba-treated animals which received untreated, isolated
EVs (Supplementary Fig. 6a–d). Thus, we assume that the
amount of GPIba antibody injected into the recipient animals to
prevent endogenous EV generation did not suffice to also
completely block the internalization of the isolated EVs which
were re-injected into these animals.
Cox1 modulates neutrophil recruitment during pneumonia.
Thromboxane A2 production during pneumonia leads to increased
endothelial ICAM-1 expression9. Expression of ICAM-1 at the
mRNA and protein level in isolated murine lung microvascular
endothelial cells (MLMVEC) was increased after exposure to
stimulated neutrophils and platelets, and this required the
expression of Cox1 in platelets, but not neutrophils (Fig. 6a,b).
We confirmed these findings by ICAM-1 immunofluorescence
analysis in MLMVECs (Fig. 6c). In agreement with this observation,
immunofluorescence staining of lung sections from WT and
Cox1 / mice showed decreased ICAM-1 expression in
Cox1 / mice during pneumonia (Fig. 6d). To investigate the
ICAM-1-dependent migration of neutrophils through the lung, we
performed confocal microscopy of viable lung sections ex vivo
(Fig. 6e; Supplementary Movies 1 and 2). Neutrophils in lungs from
Cox1 / mice and in lungs from WT animals pretreated with a
blocking ICAM-1 antibody showed a significantly reduced
migration velocity (Fig. 6f) and distance relative to untreated
Figure 4 | EV-mediated shuttling of arachidonic acid into platelets is necessary for host defence. Isolated PMNs, PLTs or both were pretreated with
blocking antibodies against P-selectin (clone RB40.34, 5 mgml 1) or GPIba (clone Xia.B2, 5 mgml 1) and stimulated with ADP (10 mM) and fMLP (10mM)
at 37 C for 30min. (a) EVs were quantified in the supernatant (n¼4). (b) The arachidonic concentration in the EV fraction was quantified by ELISA
(n¼4). (c) Uptake of fluorescently-labelled, isolated neutrophil EVs (labelled with a green fluorescent cell tracker) in isolated platelets labelled with a
CD41-PE antibody (dilution 1:200) was analysed by confocal microscopy (exemplary micrograph, scale bar equals 10mm). (d) Uptake of neutrophil-derived
EVs into platelets (exemplary micrograph, scale bar equals 10mm). (e) Colocalization of EVs and Cox1 in platelets (exemplary micrograph, scale bar equals
5 mm). PMNs and platelets were isolated fromWTmice and treated with a blocking antibody against GPIba. (f) TxB2-C14 in control and ADP (10 mM)/fMLP
(10mM)-stimulated samples after pretreatment with a blocking GPIba-antibody (clone Xia.B2, 5 mgml 1) with or without substitution of isolated EVs
(n¼ 3). (g) Total TxB2 production in control and ADP/fMLP-stimulated samples (n¼ 3). (h) Cox1 activity after treatment with isotype, blocking antibody
against GPIba (clone Xia.B2, 5 mgml 1) or blocking GPIba antibody and isolated EVs (n¼ 3). Wild-type mice pretreated with the isotype or blocking
antibody against GPIba (clone Xia.B2, 50mg per mouse) were injected intratracheally with viable E. coli and (i) the amount of circulating platelet-neutrophil
aggregates in the blood, (j) neutrophil recruitment into the alveoli and the c.f.u. count in the BAL (k), lung tissue (l) and the spleen (m) were analysed after
24 h (n¼4). (n) Wild-type mice were pretreated with GPIba blocking antibody (clone Xia.B2, 50mg per mouse) and received isolated neutrophil EVs or
control and survival was assessed 24h after instillation of 8 106 viable E. coli (n¼ 7–8). Isolated PMNs and platelets were pre-incubated with a blocking
antibody against GPIba (clone Xia.B2, 5 mg ml 1) or isotype control and stimulated with ADP (10 mM) and fMLP (10 mM) at 37C for 30min. The
concentration of LTB4 (o) and LTC4 (p) was measured in the supernatant (n¼4). Mean±s.e.m., ANOVA plus Bonferroni testing, two-tailed t-test in 4b,
log rank test in 4n *Po0.05.
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controls (Fig. 6g). To investigate whether ICAM-1 contributes to
neutrophil recruitment and bacterial clearance in our model of
E. coli-induced pneumonia, mice were injected with a blocking anti-
ICAM-1 antibody before inducing pneumonia. Blocking ICAM-1
caused a significantly decreased number of neutrophils in the BAL
after instillation of E. coli (Fig. 6h) and a significantly increased c.f.u.
count in the BAL, lung and spleen with no additional effect when
ICAM-1 was blocked in Cox1 / mice (Fig. 6i–k).
Discussion
We have demonstrated that the interaction of platelets with
neutrophils is required for enhancing thromboxane production
from activated platelets. Cox1 in platelets was required for
the production of thromboxane A2 using predominantly
neutrophil-derived arachidonic acid as a substrate, and the
physical proximity between platelets and neutrophils led to
enhanced Cox1 activity. Mechanistically, neutrophil-derived
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(clone Xia.B2, 50mg per mouse) and received isolated neutrophil EVs pretreated with or without a blocking Mac-1 antibody. Survival was assessed 24 h
after instillation of 8 106 viable E. coli (n¼6–7). (i) Cox1 activity in WTneutrophils alone or after co-incubation with activated WTor Cox1 / platelets
(n¼ 5). Mean±s.e.m., ANOVA plus Bonferroni testing, log rank test in 5 h *Po0.05.
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Figure 6 | Cox1 modulates neutrophil recruitment during pneumonia. MLMVEC were isolated from WTmice and co-incubated with platelets and
PMNs and ICAM-1 mRNA expression (a) and ICAM-1 surface expression (b) were analysed (n¼4). (c) Exemplary immunofluorescence staining of
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arachidonic acid was shuttled from neutrophils to platelets by
EVs, and this process required the binding of GPIba on platelets
after the initial P-selectin-mediated contact. EV liberation from
neutrophils and uptake by platelets was found to be a directed
process involving clathrin and Mac-1. Furthermore, we showed
that Cox1-mediated thromboxane production from platelets is
required for sufficient neutrophil recruitment into the lung and
efficient bacterial clearance during bacterial pneumonia. In
addition, thromboxane production was required for increased
ICAM-1 expression on endothelial cells.
Platelets are a well-recognized part of the innate immune
response to pathogenic infections6,33. Platelets possess a rich
intravascular storage of pro-coagulatory and pro-inflammatory
mediators, but are also capable of synthesizing lipid mediators33.
Thus, platelets are involved in numerous inflammatory processes,
such as acute lung injury, renal ischemia–reperfusion injury and
sepsis8,9,13,19,34,35. In addition, platelets have been shown to be an
element of immune surveillance against invading pathogens in the
liver36. Here, we provide experimental evidence that platelets rely
on neutrophils to supply arachidonic acid substrate for maximal
thromboxane generation during inflammatory conditions, which is
in line with previous reports37. Maugeri and colleagues discovered
that prostaglandin synthesis is dependent on neutrophils providing
arachidonic acid to platelets38 and that the close proximity of
platelets and neutrophils allows for the transcellular metabolism
of eicosanoids between the cells37. Furthermore, it is known that
the bilateral exchange of metabolites is required for the production
of LTB4 and LTC4 (ref. 39). However, molecular mechanisms
responsible for transcellular lipid metabolism have remained
unexplained. Using an approach with radioactive-labelled
arachidonic acid, we demonstrated that efficient platelet
thromboxane generation requires eicosanoid metabolites
originating from neutrophil arachidonic acid.
We show now that a mechanism for the transcellular
communication between neutrophils and platelets involves EVs
and that the EV-mediated metabolite shuttling requires GPIba and
P-selectin. Furthermore, we demonstrate that the EV release by
neutrophils and their uptake into platelets is a directed process. We
find the endosomal marker caveolin-1 to be expressed on
neutrophil-derived EVs. This finding is supported by previous
studies reporting the presence of caveolin-1 on EVs from
melanoma cells in tumour patients40. Caveolin-1 also has an
important role in immune cell function and host defence32. In
particular, neutrophil caveolin-1 is involved in the pathogenesis of
pneumonia41,42. However, the role of caveolin-1 in EV substrate
shuttling between neutrophils and platelets has yet to be
investigated. Our data also suggest the presence of the vesicular
coating molecule clathrin as well as Mac-1 on neutrophil-derived
EVs and the functional importance of both molecules for the
uptake and internalization into platelets. This data is in line with a
previous study reporting that macrophage-derived EVs are
internalized into placental cells by clathrin-dependent
endocytosis inducing pro-inflammatory cytokine release43. This
is, to our knowledge, the first report indicating that intercellular
transport of metabolic substrates is specifically mediated by EV
shuttling between neutrophils and platelets, and not the other way
from platelets to neutrophils. While we could identify this route of
intracellular substrate transport form neutrophils to platelets
in vitro, we cannot fully rule out that the vice versa route from
platelets to neutrophils may also play a role in vivo. Indeed, it
has been reported that platelet microparticles may be internalized
into neutrophils in a 12(S)-HETE-dependent manner during
inflammatory arthritis44. Previous studies also indicate that
opsonized bacterial particles may induce the release of
neutrophil-derived EVs with antibacterial properties45.
Furthermore, different stimuli may induce the generation and
release of different EV subsets with divergent molecular
composition and antibacterial functions46. Interestingly, we did
not detect significant alterations in the concentration of EVs after
E. coli pneumonia induction between control and platelet-depleted
mice. This may be explained by the fact that EV shuttling from
neutrophils to platelets represents a process in the immune cell
recruitment taking place at the emigration of neutrophils from the
microvasculature into the lung tissue, eventually enabling the
neutrophils to enter the alveolar space. Another explanation
may be that different mechanisms of EV generation in the
alveolar compartment and secretion into the BAL are involved
apart from platelet-neutrophil interactions. The exact temporal-
spatial contribution of EV shuttling to the distinct process of
neutrophil recruitment has yet to be investigated in detail to
gauge the role of detectable neutrophil-derived EVs in the
bronchoalveolar lavage fluid.
Research over the past several years has identified an important
role for cyclooxygenases and their metabolites in inflammatory
processes47–52. However, to this date it was unknown which
conversion enzyme in platelets is necessary for utilization of
neutrophil eicosanoid metabolites to booster platelet thromboxane
generation. In our study, we identified Cox1 as the prevalent
cyclooxygenase responsible for thromboxane generation using
neutrophil-derived arachidonic acid as a substrate. This is in line
with a recent report demonstrating that the platelet Cox1 signalling
pathway regulates leukocyte activation and affects disease
progression during systemic inflammatory disorders53. On first
glance it may appear surprising that platelets depend on
arachidonic acid from neutrophil-derived EVs to efficiently
generate thromboxane, as they possess cellular arachidonic acid
storages themselves. However, this phenomenon may be explained
by our finding that the uptake of neutrophil-derived EVs not only
provides substrates to platelets, but also increases Cox1 activity in
platelets, thus optimizing and synchronizing the usage of substrates
for thromboxane generation.
Interestingly, the physical contact between platelets and
neutrophils also influences cell-autonomous functions of
neutrophils. It is known that platelet engagement causes the
upregulation of neutrophil adhesion molecules and increases ROS
production54–56. While the exact mechanism of these interactions
in vivo are still unclear, it is possible that platelets use the
neutrophil’s uropod, a PSGL-1-enriched microdomain that
protrudes into the luminal space, as a means for efficient binding
to neutrophils that first accumulate in the inflamed lungs14. The
current study establishes that one relevant mechanism of
intercellular communication within this structure is through lipid
exchange enabled by EVs. Transcellular metabolism from platelets
to neutrophils is also of importance, as neutrophils require
hydroxyeicosatetenoic acid (12-HETE) produced by platelet-
specific lipoxygenases to generate leukotrienes57. Interestingly,
this metabolic pathway also requires the binding of platelet
P-selectin to neutrophil PSGL-1, and this physical interaction
regulates the activity of the conversion enzyme LTC4 synthase
further downstream in neutrophils37,58. Thus, transcellular
metabolism between platelets and neutrophils seems to be a
bidirectional process with benefits for both cell types59. It has been
shown that the balance in this system of transcellular eicosanoid
metabolism is also affected by the activity of the respective
conversion enzymes in platelets and neutrophils. For example, a
decrease in neutrophil lipoxygenase activity results in a significant
increase in platelet thromboxane B2 by increased supply and shift
of eicosanoid substrates from neutrophils to platelets in their close
proximity60.
Prostaglandins are among the most prominent lipid mediators
released from platelets with the pro-inflammatory thromboxane
being an important mediator from this group. In this study, we
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present evidence that thromboxane generated by platelets from
neutrophil substrates is of crucial importance for leukocyte
recruitment and bacterial clearance during septic infections.
This observation is in accordance with numerous reports
demonstrating the importance of thromboxane for the
development of an immune response against invading pathogens.
For example, thromboxane has been implicated in the governance
of endothelial cell inflammation61, in the regulation of vascular
permeability changes during inflammatory conditions in the
lung62 as well as in the recruitment of immune cells to the focus
of infection9,63.
In summary, we have identified a role for transcellular
prostaglandin metabolism between neutrophils and platelets,
mediated by metabolite shuttling via EVs and involving Cox1,
which affects neutrophil recruitment and bacterial killing. These
findings are of clinical importance, as the inhibition of
cyclooxygenases is a common therapeutic approach for pain relief
and anti-inflammatory therapy. In addition, the cyclooxygenase
inhibitor acetylsalicylic acid (aspirin) is widely used for platelet
inhibition in patients after cardiac bypass grafting. Thus, inhibitory
effects on neutrophil recruitment may be of great importance in
these patient collectives. Furthermore, the potential use of
cyclooxygenase inhibitors could be of potential interest for the
therapy of inflammatory disorders involving uncontrolled neu-
trophil recruitment and warrants further research in this field.
Methods
Animals and reagents. We used 8–12-week-old male C57BL/6 mice, Cox1 /
mice (Taconic, Hudson, NY, USA), and Cox2 / mice (Taconic). The mice were
kept in a barrier facility under specific pathogen-free (SPF) conditions. All animal
experiments were approved by local government authorities and were in agreement
with the National Institutes of Health Guide for the Care and Use of Laboratory
Animals. Unlike otherwise stated, all reagents were obtained from Sigma-Aldrich
(Taufkirchen, Germany).
Murine pneumonia model. We used a murine model of E. coli induced pneumonia
as published by Ittner and colleagues64. Overnight cultures (37 C) of E. coli (ATCC
strain 25922) were grown in Tryptic Soy medium, washed and resuspended in sterile
saline (0.9%). Mice were anaesthetized by intraperitoneal injection of ketamine
(125mg g 1 body weight; Pfizer, New York, USA) and xylazine (12.5mg g 1 body
weight; Bayer, Leverkusen, Germany). We used two different sets of experiments. For
the first set of experiments, animals were challenged with 6 106 viable E. coli per
mouse. At this inoculation dose, all mice survived the 24h observation period. In a
separate set of experiments, mice were challenged with a higher inoculation dose
(8 106 viable E. coli per mouse) which allowed the survival analysis. After 24 h, the
mice challenge with 6 106 viable E. coli were sacrificed and the lungs were lavaged
five times with 0.7ml physiologic saline solution. The number of neutrophils in the
BAL was counted using kimura staining. Neutrophils were counted using an
improved Neubauer counting chamber and an inverted cell culture microscope
(Primovert, Carl Zeiss, Go¨ttingen, Germany) equipped with a 10 0.75 NA
objective. A total of 4 fields with 16 standardized subfields in each individual field
were counted for each sample. For some experiments platelet depletion in WT mice
was achieved by intraperitoneal administration of busulfan as described
previously8,65. The application of busulfan decreases platelet counts by 490%
(ref. 8). PMNs were depleted in some mice by injection of anti-Ly6G antibody
(clone 1A8, 200mg per mouse i.p., Biolegend). Colony-forming units in the lung,
blood and spleen were counted by serial plating on TSA agar plates64. For the
Klebsiella pneumoniae-induced pneumonia model, mice were intratracheally instilled
with 2 107 viable K. pneumoniae (ATTC strain 13883).
Intravital microscopy of the lung. Intravital microscopy of the lung was
performed as described previously8,66. Briefly, animals were anaesthetized and
mechanically ventilated. A thoracotomy was performed to expose the right middle
lung lobe and the lung was hold in position using a custom-built fixation device
with an integrated observation window66. Immediately before imaging animals
were injected with an Alexa488-coupled anti-Gr1 antibody (clone RB6-8C5, 5 mg
per mouse, purified from hybridoma supernatant) and a PE-coupled anti-CD41
antibody (clone MWReg30, 5 ml per mouse, BD Biosciences, Franklin Lakes, NJ,
USA). High-speed multichannel fluorescence microscopy was performed on an
upright microscope (Axioskop; Carl Zeiss, Go¨ttingen, Germany) equipped with a
Lambda DG-4 ultra high speed wavelength switcher (Sutter Instruments, Novato,
CA, USA) and a 40 0.75 NA saline immersion objective. Videos were recorded
with a digital camera (Sensicam QE) and analysed with Slidebook Software
(Version 5; Intelligent Imaging Innovations, Go¨ttingen, Germany).
Quantification of platelet–neutrophil interactions in vivo. Whole blood
samples were withdrawn from mice and stained with Alexa633-coupled anti-Gr1
antibody (clone RB6-8C5, dilution 1:100), PE-coupled anti-CD41 antibody
(clone MWReg30, dilution 1:100, BD Biosciences), FITC-coupled anti-Ly6B2
antibody (clone 7/4, dilution 1:100, AbD Serotec, Du¨sseldorf, Germany), and
PerCP-coupled anti-CD45 antibody (clone 30-F11, dilution 1:100, BD Biosciences).
Platelet-neutrophil aggregates were quantified by measuring the percentage of
CD41þ neutrophils (CD45þGr1þ7/4þ ) using a flow cytometer (BD FACSCanto
II, BD Biosciences).
Thromboxane determination by radioimmunoassay. Thromboxane was quanti-
tated using a radioimmunoassay. Neutrophils and/or platelets (ratio 1:10) were loaded
with C14-labelled arachidonic acid (Perkin Elmer, Waltham, MA, USA). After
stimulation with 10mM ADP and 10mM fMLP at 37 C for 30min, C14-TxB2 was
immunoprecipitated from the supernatant and detected by measuring the -radiation
activity using a TRI-CARB 2900 TR liquid scintillation counter (Packard Instruments,
Meriden, CT, USA). Total TxB2 levels were measured using an ELISA kit according to
the manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA).
EV preparation and quantification. For the generation of isolated neutrophil EVs
the cells were stimulated with fMLP and EVs were purified from the supernatant
using the ExoQuick-TC kit and EV quantification was performed using the Exocet
kit according to the manufacturer’s instructions (System Biosciences, Mountain
View, CA, USA). Arachidonic acid in purified neutrophil EVs was measured by
ELISA (R&D Systems). For reconstitution experiments, isolated neutrophils
(B40 106) from wild-type bone marrow were stimulated with fMLP. EVs
(B1 108) were isolated from the supernatant and reinjected into mice 15min
after intratracheal instillation of E. coli. For in vitro assays with EV reconstitution,
neutrophil-derived EVs were added at a concentration of 2 107 EVs per ml. To
further characterize the investigated extracellular vesicles, we analysed our study
material according to the guidelines published by the International Society of
Extracellular Vesicles67. As the concomitant contamination of extracellular vesicle
preparations with apoptotic cell bodies may obscure the studied effects of
extracellular vesicles, we analysed stained EV supernatants with Trypan Blue
staining and could not detect significant amounts of contamination with apoptotic
cell remnants in our EV preparation. As suggested by the International Society of
Extracellular Vesicles we also investigated the expression of proteins that
neutrophil-derived EVs may inherit from their origin cell (that is, neutrophils).
Western blot analysis revealed that the integrins Mac1, the integrin subunits
CD11a (aL) and CD18 (b2) as well as PSGL-1 (CD162) are present in lysates from
neutrophil-derived EV preparations, all of which are also expressed on the
membrane of neutrophils, and the commonly EV-associated molecule CD63
(Supplementary Fig. 7a). In contrast, the histones H2A and H3 could not be
detected in lysates from neutrophil-derived EV preparations, as these proteins are
usually nucleus-associated and do not associate with endosomal structures. To also
show the functional dose-response relationship of the neutrophil-derived EV
isolates we blocked endogenous EV liberation in a stimulated platelet-neutrophil
co-culture in vitro and substituted isolated EVs at different concentrations to
measure the amount of TxB2 in this system and could observed increasing TxB2
generation with increasing substitution amounts of isolated neutrophil-derived EVs
(Supplementary Fig. 7b).
Western blot. Isolated EVs were lysed with RIPA buffer. Lysates were boiled with
La¨mmli sample buffer, run on 10% SDS–PAGE gels and immunoblotted using
antibodies against Caveolin-1 (Cell Signaling Technology, Danvers, MA, USA, Cat.
No. 3238, dilution 1:1,000), Clathrin (clone P1663, dilution 1:1,000, Cell Signaling
Technology) or Mac-1 (clone M1/70, dilution 1:1,000, Biolegend, San Diego, CA,
USA). Immunoblots were developed using an ECL system (GE Healthcare, Little
Chalfont, UK). Uncut western blots are supplied in Supplementary Fig. 8.
Platelet flow chamber. Rectangular glass capillaries (20 200mm) were coated
with fibrinogen (1,500mgml 1) for 2 h followed by blocking of unspecific binding
sites with casein 1% (Thermo Fisher Scientific, Waltham, MA, USA) for 1 h.
One end of the glass capillary was connected to a PE50 tubing (BD Biosciences) and
used to control the wall shear stress in the capillary. Wall shear stress was adjusted
toB20 dyne cm 2 resembling arterial flow conditions. Anticoagulated whole-blood
samples were withdrawn from WT mice and samples were stimulated with 10mm
ADP and 10mm fMLP at 37 C for 5min. The chamber was perfused for 2min
and washed with PBS for 1min. Representative fields of view were recorded
using an SW40/0.75 objective and a digital camera. The numbers of adherent
platelets per mm2 were calculated.
Transmission electron microscopy. For electron microscopy the lung was
perfused with PBS via the right ventricle, followed by 2% glutaraldehyde, 2%
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paraformaldeyde in 0.2M cacodylate buffer, pH 7.4. The lung was removed and
small samples were further fixed under low vacuum until they settled down.
The specimen was post-fixed with 1% osmiumtetroxide and 1.5% potassium
ferrocyanide, dehydrated and embedded in epon. Sixty nanometer ultrathin
sections were cut (Leica UC6 ultramicrotome, Vienna, Austria) and counterstained
with uranyl acetate and lead. Samples were inspected on a transmission electron
microscope at 80 kV (Fei-Tecnai12, FEI, Eindhoven, Netherlands) and pictured
with a CCD camera (Megaview, SIS, Mu¨nster, Germany).
Cox activity assay. Cox1 activity in supernatants was analysed according to the
manufacturer’s protocol (Cayman Chemical, Ann Arbor, MI, USA). Cox2 activity
was pharmacologically blocked by use of the specific inhibitor DuP-697.
PMN migration ex vivo. The Migration of PMNs in lung tissue ex vivo was
investigated using a technique published by Hasenberg and colleagues, with some
modifications68. Mice were injected i.t. with E. coli. After 4 h, animals were injected
with Alexa488-coupled anti-Gr1 antibody (clone RB5-8C6, 5 mg per mouse) and
Alexa568-coupled anti-PECAM (clone 390, 50 mg per mouse, BD Biosciences) to
stain neutrophils and endothelial cells, respectively. Mice were sacrificed and
lungs were filled with 1ml of low-melting agarose. After removal, lungs were cut
using a vibratome. Lungs were fixed in a cell culture dish, submersed in PBS and
time-lapse z-stacks were recorded using a spinning disc confocal microscope
(CellObserver SD, Zeiss, Go¨ttingen, Germany) equipped with a 20 /1.0 NA
objective. Neutrophil migration velocity and displacement were analysed
using FIJI69.
MLMVEC isolation and analysis of ICAM-1 expression. Murine lung micro-
vascular endothelial cells (MLMVEC) were isolated and cultured from murine
lungs. Lungs were mechanically minced and enzymatically digested with
20mgml 1 collagenase A (Roche, Basel, Switzerland) at 37 C for 2 h. Dynabeads
(Life Technologies, Carlsbad, CA, USA) were incubated with anti-PECAM-1
antibody (clone Mec13.3, 30 mg per 200 ml, purified from hybridoma supernatant)
at 4 C for 24 h. Lung homogenisates were incubated with dynabeads at 4 C for
45min, followed by magnetic separation of the dynabeads from the supernatant.
MLMVEC cells were culture on gelatin-coated dishes for 4–7 days. The mRNA
from MLMVEC was extracted using Trizol extraction (peqGOLD TriFast, Peqlab,
Erlangen, Germany). mRNA was transcribed into cDNA using M-MLV reverse
transcriptase. Quantitative expression analysis by qRT-PCR was performed using
primers specific for murine ICAM-1 and GAPDH70. Surface expression of ICAM-1
was analysed using immunofluorescence staining and flow cytometry as described
previously9.
Immunofluorescence staining. Platelet/neutrophil co-cultures isolated neu-
trophils and platelets were immobilized on poly-L lysine coated plastic dishes
(8-well slide, Ibidi) and fixed with 4% paraformaldehyde. After blocking, samples
were incubated with antibodies against Ly6G (clone 1A8, dilution 1:100, Biole-
gend), CD49b (clone H2Ma, dilution 1:100, Biolegend), LBPA (clone 6C4, dilution
1:100, Echelon Biosciences) and Cox1 (clone H-62, dilution 1:100, Santa Cruz
Biotechnologies) at 4 C overnight. Secondary staining was performed with Alexa-
Fluor coupled secondary antibodies (all from Invitrogen). Hoechst 33442 was used
for nuclear counterstaining. Images were acquired using a LSM780 confocal
microscope (Carl Zeiss) equipped with a 63 immersion objective. Images were
analysed using ZEN 2 software (Carl Zeiss).
Statistics. Statistical analysis was performed with SPSS (version 22.0) using
Wilcoxon-test or t-test as appropriate. More than two groups were compared using
one-way ANOVA followed by Bonferroni testing. Data distribution was assessed
using Kolmogorov–Smirnov test or Shapiro–Wilks test. Survival analysis
was performed using log-rank test. All date are represented in means±s.e.m.
A P valueo0.05 was considered as statistically significant. For in vivo experiments,
the provided n is the number of animals used per experiment. For in vitro
experiments, n describes the number of independent experiments, each done at
least in technical triplicates.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
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